Melanocytic nevus overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
==Medical Therapy== | ==Medical Therapy== | ||
==Surgery== | |||
==References== | ==References== | ||
Revision as of 15:13, 1 September 2015
|
Melanocytic nevus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanocytic nevus overview On the Web |
|
American Roentgen Ray Society Images of Melanocytic nevus overview |
|
Risk calculators and risk factors for Melanocytic nevus overview |
Editors-In-Chief: Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [1]; Michel C. Samson, M.D., FRCSC, FACS [2]
Overview
A mole, technically known as a melanocytic nevus, is a small, dark spot on human skin. According to the American Academy of Dermatology, the majority of moles appear during the first two decades of a person’s life while about one in every 100 babies are born with moles. Acquired moles are a form of benign neoplasm, while congenitalmoles are considered a minor malformation, or hamartoma. A mole can be either subdermal (composed of melanin), or a pigmented growth on the skin, formed mostly of a type of cell known as melanocytes. The high concentration of the body’s pigmenting agent, melanin, is responsible for their dark color. Moles are a member of the family of skin lesions known as naevi.